The SiShield Advantage
SiShield Proprietary anti microbial products & formulas are used to modify almost any surface on a molecular level, rendering those surfaces and products free from microbial contamination and cross contamination.
This anti microbial protection is strong, durable, invisible, and very effective against both, gram positive and gram negative bacteria, algae, yeasts, mold and mildew, and broad a spectrum of other microorganisms.
SiShield anti microbial products contain no heavy metals, tin, lead, mercury or formaldehyde, and are used in a broad range of applications by textile and carpet manufacturers, retail-household care market producers, industrial and institutional product companies, paint and coating manufacturers, cosmetics and toiletry manufacturers, environmental service providers and network operators, and healthcare companies.
The Power to Protect and Disinfect
Protect your products with our value-adding SiS AM500 or SiS AM7200 antimicrobial agents, and discover the benefits and the advantages.
Microbial contamination and cross-contamination in schools, hospitals, work places and public buildings, and the public concern for the spread of infectious diseases have created a great essential need for products and surface treatments that inhibit, kill and protect against bacteria, algae, yeast, mildew, viruses and a broad spectrum of other microorganisms.
As a result, companies are discovering the value-added benefits of using our antimicrobial products, SiS AM500 or SiS AM7200, to meet this consumer demand. The power of our products to protect and disinfect are based on the use of siloxane quaternary ammonium compounds as antimicrobial agents, which are found to be very effective, non-migrating, non-leaching and environmentally friendly. Our unique antimicrobial products are easy to use in homes and buildings, easy to incorporate into other materials and surfaces and easy to formulate into a variety of consumer products.
Our Mission
Provide anti microbial & long lasting Protection to substrates because no matter how hard you are cleaning, it may not be enough!
more
What’s New
June 3, 2011
INHIBIT MARSA WITH SISHIELD PRODUCTS
A COMPLETELY new form of the MRSA superbug has been found in two Dublin hospitals. This new organism probably arose in animals and then jumped across to infect humans, according to the Irish researchers who discovered it.
“It is totally different. It has never been seen before in any living organism,” said Prof David Coleman of Trinity College Dublin, who led an international team that identified the bacterium.
The organism was so different that existing test kits could not recognize it as being an MRSA-type bacterium. “I have never seen anything as divergent, which means it has evolved away from humans,” Prof Coleman said yesterday.
MRSA (Methicillin Resistant Staphylococcus Aureus) describes organisms that have developed strong resistance to most antibiotics, something that makes MRSA infections very difficult to treat in humans.
The superbug is endemic in some Irish hospitals, according to a number of studies, including a report last year, MRSA in Ireland.
It put the cost of hospital-acquired infections at €23 million per year. Those who picked up a hospital-acquired MRSA infection were seven times more likely to die than patients who did not become infected.
This new organism may add to the ongoing burden of hospital-acquired infections, given it is so very different to existing strains. “This is not just a new strain, this is absolutely and totally different from anything since MRSA was discovered in the 1960s,” Prof Coleman said.
Prof Coleman, in collaboration with the National MRSA Reference Lab at St James’s Hospital and the University of Dresden and Alere Technologies in Germany, analyzed DNA taken from the bug.
They found it was genetically similar to types of MRSA found in cows and other animals, strongly suggesting the new MRSA originated in animals, he said. “The organism has crossed from an animal population into humans.”
Cases were discovered in Dublin and cases were also later found in Germany. As the study progressed, Prof Coleman’s group became aware of similar but wholly separate research into this new superbug was under way at the University of Cambridge and the Welcome Trust Sanger Institute in the UK.
The Cambridge group found the same organism in cows and humans in the UK and in Denmark, Prof Coleman said.
For this reason the two groups published their findings simultaneously yesterday, the Irish-German team in the journal Antimicrobial Agents and Chemotherapy and the UK group in Lancet Infectious Diseases.
This new organism is similar to existing MRSAs in terms of its antibiotic resistance and virulence, he said. Unfortunately the organism can readily share its very different genetic make-up and its antibiotic resistance by passing it on to other bacteria. This means it is capable of sparking the creation of new types of superbugs.
Funding for the Irish-led research came from the Dublin Dental University Hospital Microbiology Unit.
April 29, 2009
SWINE FLU PREVENTION
With the outbreak of Swine Flu in Mexico and the United States, everyone is wondering, “how bad will this get?” The answer of course is, no one really knows. The worst-case scenario is a worldwide pandemic. Thirty percent of the US or some 90 million Americans would likely get sick. Two million Americans would likely succumb and die from the flu. Much of our daily routines would be put on hold as offices, schools, and even houses of worship close to discourage congregating and allowing the further spread of the virus.
Source: AP.com article: In flu crisis, US has planned for the worst, accessed April 28, 2009 1:10 PMAccording to health officials the best way to head-off this horrific possibility is to prevent its spread. Once someone is infected, anti-viral medication and typical flu management are really all we have currently to battle influenza. Stopping it before it starts is the best approach.
SiShield is working to have one of its unique antimicrobial products tested for efficacy in preventing the spread of the A/H1N1 virus, commonly known as Swine Flu, on surfaces and substrates. With laboratory research showing its efficacy killing and inhibiting the growth of a highly pathogenic Avian Influenza virus (H5N1), Staphylococcus aureus (the main cause of staph infections), as well as Bacillus anthracis (anthrax), we do expect to see similar positive results with the Swine Flu virus.
Please note, our product has a patent pending and one of its actives is registered with the EPA as an anti-microbial agent. This product is NOT yet registered with the EPA for use against Swine Flu virus.